Log In
BCIQ
Print this Print this
 

Invicorp (PSD510)

Also known as: vasoactive intestinal peptide (VIP/phentolamine)

  Manage Alerts
Collapse Summary General Information
Company Plethora Solutions Holdings plc
DescriptionSelf injection formulation of vasoactive intestinal peptide (VIP) and phentolamine, an adrenergic receptor alpha (ADRA) antagonist
Molecular Target Vasoactive intestinal peptide receptor 1 (VPAC1) ; Vasoactive intestinal peptide receptor 2 (VPAC2)
Mechanism of ActionVasoactive intestinal peptide receptor 1 (VPAC1) agonist; Vasoactive intestinal peptide receptor 2 (VPAC2) agonist
Therapeutic ModalitySmall molecule: Combination
Latest Stage of DevelopmentMarketed
Standard IndicationErectile dysfunction (ED)
Indication DetailsTreat erectile dysfunction (ED)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$789.0M

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

11/04/2015

$789.0M

0

0

Get a free BioCentury trial today